AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06593119 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Usual Care
Description: This includes usual clinic based HTN care using routinely available clinic resources (e.g., community health worker, social worker). Clinicians can offer self-management support (e.g., dietician referral) or recommend a home BP monitor. These activities mirror current primary care practice.
Study NCT06594003 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency
Description: There has recently been considerable interest in the role of radiofrequency ablation (RFA) of the genicular nerves for KOA. In the majority of previous studies, ablation was done via a radiofrequency technique using either fluoroscopy or ultrasound for only three genicular nerves, whereas the knee joint is also supplied by a few other nerves . Interestingly, neurolytic agents can also be used to ablate the nerves, and are readily available, less costly, and need less logistic support
Study NCT06594081 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention podcasts
Description: Students in the experimental group will listen to podcasts.
Study NCT06596239 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: lower-clear-plate-based intermaxillary traction (LCP-IMT)
Description: The patient is instructed to apply elastics between the upper molar bands and the hooks on the lower clear plates.
Study NCT06596239 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Removable mandibular retractor (RMR)
Description: An appliance is worn on the upper jaw, which affects the lower jaw by using an inferiorly extended labial bow.
Study NCT06601816 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: maxillary sinus lift with reamer
Description: Lateral window created with specially designed burs for lateral sinus lift
Study NCT06601816 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: maxillary sinus lift with piezzo
Description: lateral window was created using piezo surgery and surgical guide
Study NCT06601816 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: maxillary sinus lift with conventional burr
Description: the lateral window was created with conventional rotary instrument burs
Study NCT06601803 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sterile saline solution
Description: The shoulder will be washed with normal sterile saline before and after placing the shoulder implant
Study NCT06601803 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Surgiphor
Description: The shoulder will be washed with Surgiphor (Povidone Iodine) before and after placing the shoulder implant
Study NCT06601803 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sample Collection
Description: During the surgical procedure, 4 swabs of the surgical wound will be taken at various times throughout the procedure
Study NCT06590311 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Heart Rate Variability
Description: Heart rate variability evaluation through different domains
Study NCT06603025 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: chewing gum
Description: Preoperative intervention group patients will chew sugarless gum for at least 30 minutes 30-60 minutes before surgery. The gum will be removed before going to the operating room.
Study NCT06653959 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: active Transcranial Magnetic Stimulation
Description: Based on each individual's MRI data, individualized stimulation targets will be found, and then this will be used for stimulation for 5 consecutive days.
Study NCT06653959 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: sham Transcranial Magnetic Stimulation
Description: Based on each individual's MRI data, individualized stimulation targets will be found, and then this will be used for sham stimulation for 5 consecutive days.
Study NCT06655506 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: ERAS group
Description: This group will include patients that achieved a compliance rate that exceeded 80% of the required predetermined criteria of ERAS protocols.
Study NCT06655506 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: Control group
Description: This group will include patients that do not follow the predetermined criteria of ERAS protocols
Study NCT06600139 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Collaboration-Screening-Referral (SSH) model
Description: The SSH aims to identify parents in need of mental health support and to strengthen social workers' competence in addressing mental illness. The SSH includes three components: 1) Collaborating - establishing collaboration with local services offering support to adults with mental illness, 2) Screening - using screening instruments for depression (the Patient Health Questionnaire - PHQ-9) and anxiety (GAD-7) to identify symptoms of mental illness among parents, and 3) Referral - Discussing the results of the screening with parents and referring to appropriate services. Techniques from motivational interviewing are included. Social workers receive training and material to administer the screening and refer parents in need of support.
Study NCT06604130 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Prostate cancer screening decision
Description: The subjects would receive serum PSA test.
Study NCT06587828 — intervention group
Intervention type: PROCEDURE
Intervention: Companion blood samples with procedure
Description: Participants in all cohorts will have a companion blood sample obtained on or around the time of the procedure intended to obtain tissue or fluid.
Study NCT06591637 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fertility supportive behavior education based on Watson's Theory of Human Care
Description: In this study, Watson's Theory of Human Caring guided the development of a care framework and nursing intervention for women with infertility. The researchers adapted the theory and focused on six of the ten carative factors : 1) Adopting values of humanity and devotion; 4) Developing supportive care relationships; 6) Using problem-solving methods for informed decisions; 7) Tailoring teaching to individual needs; 8) Creating a comfortable, peaceful environment; 9) Assisting with basic needs. The nursing care program, integrated with IVF treatments (14-18 days), involved four transpersonal interviews lasting 45-90 minutes each. These interviews were recorded in notes, used to individualize future sessions. The approach included active listening, empathy, and support, with participants encouraged to keep diaries for discussion. Communication was maintained in person, by phone, or email.
Study NCT06591637 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Routine nursing care
Description: Routine nursing care during IVF treatment includes:~Pre-Treatment Counseling: Providing information and addressing patient questions.~Monitoring and Assessment: Regular checks of health, hormone levels, and ovarian function.~Medication Administration: Giving prescribed fertility drugs and other medications.~Assisting with Procedures: Preparing and assisting with egg retrieval and embryo transfer.~Emotional Support: Offering emotional and psychological support. Education: Instructing on medication use, self-care, and recognizing complications.~Follow-Up Care: Scheduling and managing follow-up appointments to monitor progress
Study NCT06591637 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Routine nursing care
Description: Routine nursing care during IVF treatment includes:~Pre-Treatment Counseling: Providing information and addressing patient questions.~Monitoring and Assessment: Regular checks of health, hormone levels, and ovarian function.~Medication Administration: Giving prescribed fertility drugs and other medications.~Assisting with Procedures: Preparing and assisting with egg retrieval and embryo transfer.~Emotional Support: Offering emotional and psychological support. Education: Instructing on medication use, self-care, and recognizing complications.~Follow-Up Care: Scheduling and managing follow-up appointments to monitor progress
Study NCT06591637 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: The booklet Fertility-Supporting Health Training
Description: This booklet was prepared in line with the relevant literature and contained educational content aimed at improving healthy lifestyle behaviours . The training booklet included information on the effects of factors such as obesity, weakness, exposure to environmentally harmful substances, smoking and caffeine use on fertility and the methods of coping with these factors. In addition, information on how to use proper nutrition, develop exercise habits and cope with stress was provided. The booklet was distributed to the women at at the onset of the study.
Study NCT06591637 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The booklet Fertility-Supporting Health Training
Description: This booklet was prepared in line with the relevant literature and contained educational content aimed at improving healthy lifestyle behaviours . The training booklet included information on the effects of factors such as obesity, weakness, exposure to environmentally harmful substances, smoking and caffeine use on fertility and the methods of coping with these factors. In addition, information on how to use proper nutrition, develop exercise habits and cope with stress was provided. The booklet was distributed to the women at at the onset of the study.
Study NCT06591754 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ISTDP
Description: Both the individual therapy and the group therapy is based on ISTDP (Intensive Short-Term Dynamic Psychotherapy), an affect-focused psychodynamic therapy method. The therapy focus on the relationship between feelings, anxiety and dysfunctional emotion regulation (i.e. defenses). The purpose is to increase the capacity of anxiety regulation in the patient and to help the patient identify the dysfunctional patterns developed to avoid internal stress and then gradually approach previously warded of feelings. The individual therapy consists of 25 weekly sessions. The group treatment consists of 18 weekly sessions and is structured in three phases. Phase one: Psychoeducation about anxiety and exercises in anxiety regulation. Phase two: patients takes turn to observe their own anxiety and defenses together with a therapist. Phase three: Every session two patients will work with a chosen problem and identify defenses, anxiety and feelings together with a therapist in front of the group.
Study NCT06603480 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Aerobic exercise (moderate intensity) at 50-70% of maximum heart rate for 60 minutes, 3 days a week for 12 weeks
Study NCT06603480 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Patients who started Metformin 2\*1
Study NCT06599892 — intervention group
Intervention type: OTHER
Intervention: Intervention mapping
Description: Intervention mapping is a model combining patient and professional questionnaires and a qualitative survey using individual interviews with patients and focus groups with professionals to identify the obstacles and levers to change at the level of patients, professionals and organisations.
Study NCT06591325 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: The RT program was performed in the morning and in groups, three days per week (Mondays, Wednesdays, and Fridays), in the University fitness facility over 12 weeks. Participants were personally supervised by Physical Education professionals (1-2 supervisors per exercise session) with substantial RT experience to ensure consistent and safe exercise performance. Throughout the intervention period, the RT program was carried out on machines and free weights (Ipiranga Fitness, Presidente Prudente, SP, Brazil). The training program was carried out in groups. Participants performed four exercises for the trunk and upper limbs (chest press, seated row, triceps pushdown, preacher curl) and four exercises for the lower limbs (horizontal leg press, leg extension, lying leg curl, seated calf raise) in three sets of 10-15 repetitions based on previous guidelines (9,22).
Study NCT06591325 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control
Description: maintaining the daily routine
Study NCT06595563 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab emtansine
Description: T-DM1 will be administered IV at a dose of 3.6 mg/kg every 3 weeks. (21 days +/- 3 days) until disease progression, unacceptable toxicity or request of the subject to withdraw from the study. The total dose will depend on the subject's weight on day 1 of each T-DM1 cycle.
Study NCT06600399 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: glioblastoma
Description: All patients underwent conventional MRI, ASL perfusion imaging and 68Ga-PSMA-11 PET/CT examinations within 1 week interval
Study NCT06599788 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-paced work
Description: Participants will choose their own pace during the box-lifting protocol
Study NCT06599788 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-paced work
Description: Participants will choose their own pace during the box-lifting protocol
Study NCT06599788 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reduced-pace work
Description: Participants will work at a 25% reduced pace during the box-lifting protocol
Study NCT06599788 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Reduced-pace work
Description: Participants will work at a 25% reduced pace during the box-lifting protocol
Study NCT06599788 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Increased-pace work
Description: Participants will work at a 25% increased pace during the box-lifting protocol
Study NCT06599788 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Increased-pace work
Description: Participants will work at a 25% increased pace during the box-lifting protocol
Study NCT06599788 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Additional rest breaks
Description: Participants will choose their own pace during the box-lifting protocol and have superimposed 5 minutes of rest every 15 minutes.
Study NCT06599788 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Additional rest breaks
Description: Participants will choose their own pace during the box-lifting protocol and have superimposed 5 minutes of rest every 15 minutes.
Study NCT06595745 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Wolbachia induced incompatible mating
Description: The intervention will be performed by weekly release of male Aedes aegypti carrying Wolbachia (wAlbB strain) to mate with wild females, resulting in the death of their eggs for birth control. Before release, these males will be irradiated with X-rays to minimize the chance of any residual fertile female releases. The intervention will lead to Ae. aegypti population suppression or even elimination and preventing dengue transmission in release sites.
Study NCT06595745 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Standard traditional chemical mosquito control
Description: Traditional and commonly used chemical insecticide will be applied to reduce the mosquito population
Study NCT06595745 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Standard traditional chemical mosquito control
Description: Traditional and commonly used chemical insecticide will be applied to reduce the mosquito population
Study NCT06595797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS9531
Description: HRS9531
Study NCT05365217 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nonacog beta pegol
Description: Nonacog beta pegol is administered as intravenous injections. Participants will receive nonacog beta pegol as prophylaxis, as on-demand for treatment of bleeding episodes and in relation to surgery.
Study NCT06595797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS9531placebo
Description: HRS9531placebo
Study NCT06592807 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Perioperative Warm Socks
Description: The socks to be used in the study were provided by the researcher. The socks were suitable for foot sizes 36-45. The socks were white and made of cotton fabric. The socks were sterilized in an autoclave before use. The socks were put on the patients just before the surgery. The socks were heated to 40 degrees with an intravenous fluid warming machine.The socks remained on the patients feet throughout the surgery. After the surgery, the patients socks were removed and new heated socks were put on. The socks were kept on the patients feet for 1 hour. All socks were used for single use.
Study NCT04983680 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MBCT
Description: Mindfulness-Based Cognitive Therapy (MBCT) is an 8-week group intervention (1.5-hour weekly sessions) that combines cognitive-behavioral therapy and mindfulness training. In this study, MBCT has been adapted to include education about cardiac health and fear of recurrence, and the intervention is delivered remotely via synchronous group videoconference. There is 15-20 minutes of daily mindfulness practice between sessions. Participants are provided a home practice record form and asked to submit the completed form to study staff each week.
Study NCT05304195 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Glucocerebrosidase
Description: Blood sample (10ml) for GCase activity
Study NCT05304195 — intervention group
Intervention type: GENETIC
Intervention: GBA gene
Description: Blood sample (10ml) for variants or mutations of the GBA gene
Study NCT05304195 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Macrophage biomarkers
Description: Blood sample (20ml) for macrophage biomarkers
Study NCT06600308 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walk tests
Description: Performance of the following walking tests using inertial measurement units: TUG; 10 m test at a comfortable and fast speed and TM6 (according to the recommendations of the American Thoracic Society).~At the end of each walking test, measurement of the difficulty of exertion using the Borg scale.
Study NCT06600308 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ecological (real-life) assessment of walking ability
Description: Delivery of an actimeter, inertial units and logbook for ecological assessment (in real life) of walking ability for 7 days
Study NCT06601790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immediate application of the Smart Homespital system
Description: The Smart Homespital system can be applied for the first 3 months (12 weeks), and then the primary and secondary variables will be evaluated at 3, 6, 9months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks.
Study NCT06601790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Delayed application of the Smart Homespital system after 3 months
Description: The waiting list-control group will receive general medical services for the first 3 months and will receive a Smart Homespital system for 3-6 months. Primary and secondary variables will be monitored between 3, 6, and 9 months. While applying the Smart Homespital system, exercise three times a week, measure sleep twice a week, and questionnaire assessments (mMRC, CRQ, EQ-5D, K-CESD) are conducted once every two weeks.
Study NCT06586203 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Polygenic Risk Score
Description: The Polygenic Risk Score (PRS) is a Class II software as a medical device (SaMD) that estimates a person's level of risk of developing a disease or associated complications before clinical signs appear. The device uses the genomic profile of the person in combination with some clinical data (i.e., age, sex, age of onset of diabetes) to compute this risk. This device further provides recommendations for personalized management of T2D for patients based on their risk score.
Study NCT06586242 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Penpulimab;Anlotinib;albumin paclitaxel;oxaliplatin;lobaplatin
Description: 200mg, intravenous infusion, 30-60 minutes per infusion, once every 3 weeks, Penpulimab:administered on the first day of each cycle Anlotinib:Body weight \<60kg, 8mg Po, body weight ≥ 60kg, 10mg Po, D 1-14, q3w
Study NCT06586242 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Penpulimab;Anlotinib;albumin paclitaxel;oxaliplatin;lobaplatin
Description: 200mg, intravenous infusion, 30-60 minutes per infusion, once every 3 weeks, Penpulimab:administered on the first day of each cycle Anlotinib:Body weight \<60kg, 8mg Po, body weight ≥ 60kg, 10mg Po, D 1-14, q3w
Study NCT06599515 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: robotic surgical platform
Description: robot-assisted laparoscopic inguinal hernia repair (rTAR)
Study NCT04852172 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: L-citrulline
Description: L-citrulline is a naturally occurring amino acid. It is produced by, and normally present in, the human body.
Study NCT04852172 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: D5 1/2NS
Description: Saline
Study NCT06592625 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811
Description: SHR-A1811
Study NCT06592625 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: Adebrelimab
Study NCT06603857 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CE Ferulic
Description: CE Ferulic serum regimen combined with laser treatment
Study NCT06603857 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sham Comparator
Description: Vehicle serum regimen combined with laser treatment
Study NCT06603857 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 1927nm (Clear and Brilliant Perméa®)
Description: non-ablative fractional diode laser